Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Perrigo Company plc PRGO

Healthcare
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract... see more

Recent & Breaking News (NYSE:PRGO)

Perrigo Announces U.S. FDA Approval for Opill® OTC Daily Oral Contraceptive

PR Newswire July 13, 2023

Perrigo Appoints Patrick Lockwood-Taylor as President and CEO

PR Newswire June 8, 2023

Perrigo to Host 1x1 Investor Meetings at the 23rd Annual Oppenheimer Consumer Growth & E-Commerce Conference

PR Newswire May 24, 2023

COUNTRY STAR MITCHELL TENPENNY AND PREVACID ANNOUNCE "BEAT THE BURN" - A LIVE TIK TOK CONCERT TO SING AWAY STRESS

PR Newswire May 16, 2023

PERRIGO ANNOUNCES U.S. FDA APPROVAL FOR NICOTINE COATED MINT LOZENGE

PR Newswire May 16, 2023

FDA Joint Advisory Committee Votes in Favor of Perrigo's Opill® Daily Oral Contraceptive for OTC Use

PR Newswire May 10, 2023

Perrigo Reports First Quarter Fiscal Year 2023 Financial Results From Continuing Operations

PR Newswire May 9, 2023

Perrigo Announces Chief Executive Officer Retirement and Succession Plan

PR Newswire May 9, 2023

PERRIGO ANNOUNCES QUARTERLY DIVIDEND

PR Newswire May 4, 2023

Perrigo to Release First Quarter 2023 Financial Results on May 9, 2023

PR Newswire April 25, 2023

Firefly® Expands Its Commitment to Sustainability with Free Recycling Program

PR Newswire April 6, 2023

Perrigo Announces New Date for Joint FDA Advisory Committee Meeting to Review Opill® Daily Oral Contraceptive for OTC Use

PR Newswire March 28, 2023

Perrigo to Present at Upcoming 12th Annual UBS Global Consumer and Retail Conference

PR Newswire March 2, 2023

Perrigo Announces FDA Approval of the Store Brand OTC Equivalent of Advil® Dual Action Tablets

PR Newswire March 1, 2023

Perrigo Launches its 3-Year Optimize and Accelerate Strategic Plan, Issues Fiscal 2023 Guidance and Introduces 2025 Financial Targets at Investor Day

PR Newswire February 28, 2023

Perrigo Reports Fourth Quarter & Fiscal Year 2022 Financial Results From Continuing Operations

PR Newswire February 27, 2023

Perrigo Increases its Quarterly Dividend

PR Newswire February 21, 2023

Perrigo to Release Fourth Quarter and Fiscal Year 2022 Financial Results on February 27, 2023, Conduct Virtual Investor Day on February 28, 2023

PR Newswire February 14, 2023

Perrigo to Host Virtual Investor Day on February 28, 2023

PR Newswire December 19, 2022

SWEDEN'S SKINCARE SENSATION ACO EXTENDS PRESENCE INTO US TIMED TO THE HOLIDAY SEASON

GlobeNewswire December 16, 2022